Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence
1997/04/01 by Adam S. Olsen, A OLSEN, Vincent C. Smith +7 · 3,362 citations
Medicine · #Bladder and Urothelial Cancer Treatments #Cohort #Cohort study #Epidemiology #Gynecology #Incidence (geometry) #Internal medicine #Medical history #Medicine #Natural history #Obstetrics #Pelvic floor disorders treatments #Pelvic floor dysfunction #Population #Retrospective cohort study #Surgery #Ureteral procedures and complications #Urinary incontinence
paper · doi:10.1016/s0029-7844(97)00058-6
published in Obstetrics and Gynecology 89(4), 501-506 (Lippincott Williams & Wilkins)
openalex publication_date 1997/04/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/06
Abstract
OBJECTIVE: To determine the incidence of surgically managed pelvic organ prolapse and urinary incontinence in a population-based cohort, and to describe their clinical characteristics. METHODS: Our retrospective cohort study included all patients undergoing surgical treatment for prolapse and incontinence during 1995; all were members of Kaiser Permanente Northwest, which included 149,554 women age 20 or older. A standardized data-collection form was used to review all inpatient and outpatient charts of the 395 women identified. Variables examined included age, ethnicity, height, weight, vaginal parity, smoking history, medical history, and surgical history, including the preoperative evaluation, procedure performed, and details of all prior procedures. Analysis included calculation of age-specific and cumulative incidences and determination of the number of primary operations compared with repeat operations performed for prolapse or incontinence. RESULTS: The age-specific incidence increased with advancing age. The lifetime risk of undergoing a single operation for prolapse or incontinence by age 80 was 11.1%. Most patients were older, postmenopausal, parous, and overweight. Nearly half were current or former smokers and one-fifth had chronic lung disease. Reoperation was common (29.2% of cases), and the time intervals between repeat procedures decreased with each successive repair. CONCLUSION: Pelvic floor dysfunction is a major health issue for older women, as shown by the 11.1% lifetime risk of undergoing a single operation for pelvic organ prolapse and urinary incontinence, as well as the large proportion of reoperations. Our results warrant further epidemiologic research in order to determine the etiology, natural history, and long-term treatment outcomes of these conditions.
Cited by
- Comparison of Levator Ani Muscle Defects and Function in Women With and Without Pelvic Organ Prolapse
- Forecasting the Prevalence of Pelvic Floor Disorders in U.S. Women
- Pelvic Floor Dysfunction: Assessment with Combined Analysis of Static and Dynamic MR Imaging Findings
- A Retrospective Cohort Study Investigating the Clinical Care Pathway for Patients at a Pelvic Mesh Complications Clinic in a Western Australian Tertiary Hospital
- Management of Complications in Laparoscopic Sacrocolpopexy: Focus on Urinary Incontinence
- Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review
- Levator ani muscle stretch induced by simulated vaginal birth. [europepmc]
- Interrater reliability and physical examination of the pubovisceral portion of the levator ani muscle, validity comparisons using MR imaging. [europepmc]
- Childbirth and pelvic floor dysfunction: an epidemiologic approach to the assessment of prevention opportunities at delivery. [europepmc]
- Biomechanical properties of the vaginal wall: effect of pregnancy, elastic fiber deficiency, and pelvic organ prolapse. [europepmc]
- Graphic integration of causal factors of pelvic floor disorders: an integrated life span model. [europepmc]
- Prevalence of symptomatic pelvic floor disorders in US women. [europepmc]
- Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors. [europepmc]
- Prevalence and risk factors for mesh erosion after laparoscopic-assisted sacrocolpopexy. [europepmc]
- Extracellular matrix proteases contribute to progression of pelvic organ prolapse in mice and humans. [europepmc]
- Predicting the number of women who will undergo incontinence and prolapse surgery, 2010 to 2050. [europepmc]
- Avulsion of puborectalis muscle and other risk factors for cystocele recurrence: a 2-year follow-up study. [europepmc]
- Conservative prevention and management of pelvic organ prolapse in women. [europepmc]
- Deterioration in biomechanical properties of the vagina following implantation of a high-stiffness prolapse mesh. [europepmc]
- Vaginal degeneration following implantation of synthetic mesh with increased stiffness. [europepmc]
- Vaginal childbirth and pelvic floor disorders. [europepmc]
- Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse. [europepmc]
- Outcomes of vaginal prolapse surgery among female Medicare beneficiaries: the role of apical support. [europepmc]
- Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. [europepmc]
- Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. [europepmc]
- Risk factors for pelvic organ prolapse and its recurrence: a systematic review. [europepmc]
- Epidemiological trends and future care needs for pelvic floor disorders. [europepmc]
- Surgery for women with anterior compartment prolapse. [europepmc]
- Development of Upright Computed Tomography With Area Detector for Whole-Body Scans: Phantom Study, Efficacy on Workflow, Effect of Gravity on Human Body, and Potential Clinical Impact. [europepmc]
- Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. [europepmc]
- Single-cell transcriptome profiling of the vaginal wall in women with severe anterior vaginal prolapse. [europepmc]
Related